Additionally, to gain a complete understanding of the biological roles of GFAT1 and VEZF1 in HCC, future studies utilizing mouse models specifically deficient in GFAT1 or VEZF1 are necessary. This evidence concerns the gene VEZF1 and hepatocellular carcinoma.